Dunn Michael J. 4
4 · CalciMedica, Inc. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Dunn Michael J.
President and COO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-09-09−11,761→ 0 totalExercise: $1.39Exp: 2024-10-01→ Common Stock (11,761 underlying) - Exercise/Conversion
Common Stock
2024-09-09$1.39/sh+11,761$16,348→ 11,761 total
Footnotes (2)
- [F1]Immediately exercisable.
- [F2]Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer (formerly known as Graybug Vision, Inc.) and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.